Merck Joins the Once-Daily Hep C Party

Merck Joins the Once-Daily Hep C Party

It was announced this week that the Food and Drug Administration (FDA) has officially approved Merck’s new once-daily regimen to...

Drug Price Wars, Episode II: Attack of the Gilead Clones

On Monday January 5, 2014, a spokesman for CVS Health Corp. (CVS) declared that HarvoniĀ® and SovaldiĀ®, which are both...

Drug Price Wars, Episode I: The High Priced Hep C Menace

Drug Price Wars, Episode I: The High Priced Hep C Menace

On December 22, 2014 Express Scripts (ESRX) announced to the public that it had reached a deal with AbbVie (ABBV),...

All original content on these pages is fingerprinted and certified by Digiprove